EP4065233 - METHODS FOR ACTIVATION AND EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 02.09.2022 Database last updated on 19.10.2024 | |
Former | The international publication has been made Status updated on 04.06.2021 | Most recent event Tooltip | 08.06.2024 | Supplementary search report | published on 10.07.2024 [2024/28] | Applicant(s) | For all designated states KSQ Therapeutics, Inc. 4 Maguire Road Lexington, MA 02421 / US | [2023/15] |
Former [2022/40] | For all designated states KSQ Therapeutics, Inc. 610 Main Street North 4th Floor Cambridge MA 02139 / US | Inventor(s) | 01 /
BENSON, Micah 27 Glenburn Road Arlington, MA 02476 / US | 02 /
COLLETTI, Nicholas John 309 Allston Street, Apt. 8 Boston, MA 02135 / US | 03 /
TUBO, Noah Jacob 6 Wildflower Drive Sutton, MA 01590 / US | 04 /
SCHLABACH, Michael 301 Pleasant Street Belmont, MA 02478 / US | [2022/40] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2022/40] | Application number, filing date | 20892396.1 | 24.11.2020 | [2022/40] | WO2020US62094 | Priority number, date | US201962940035P | 25.11.2019 Original published format: US 201962940035 P | US202063081539P | 22.09.2020 Original published format: US 202063081539 P | [2022/40] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021108455 | Date: | 03.06.2021 | Language: | EN | [2021/22] | Type: | A1 Application with search report | No.: | EP4065233 | Date: | 05.10.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.06.2021 takes the place of the publication of the European patent application. | [2022/40] | Search report(s) | International search report - published on: | US | 03.06.2021 | (Supplementary) European search report - dispatched on: | EP | 07.06.2024 | Classification | IPC: | A61P37/02, A61K35/17, A61K48/00, A61P35/00, C07K14/47, C12N5/0783, C12N9/22, C12N5/0781, A61K39/00 | [2024/28] | CPC: |
C12N9/22 (EP);
C12N5/0636 (EP,KR,US);
A61K39/4611 (EP,KR,US);
A61K39/4644 (EP,US);
A61P35/00 (EP,KR);
A61P37/02 (EP,KR);
C07K14/47 (EP);
C12N5/0068 (KR);
C12N5/0635 (EP);
A61K2121/00 (KR);
A61K2300/00 (KR);
C12N2310/20 (KR);
C12N2501/2302 (EP,KR);
C12N2501/51 (EP);
C12N2501/515 (EP,KR);
|
Former IPC [2024/12] | A61P37/02, A61K35/17, A61K48/00, A61P35/00, C07K14/47, C12N5/0783, C12N9/22, C12N5/0781 | ||
Former IPC [2022/40] | A61P37/02, A61K35/17, A61K48/00, A61P35/00, C07K14/47 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/40] | Title | German: | VERFAHREN ZUR AKTIVIERUNG UND EXPANSION TUMORINFILTRIERENDER LYMPHOZYTEN | [2022/40] | English: | METHODS FOR ACTIVATION AND EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES | [2022/40] | French: | PROCÉDÉS D'ACTIVATION ET D'EXPANSION DE LYMPHOCYTES INFILTRANT LES TUMEURS | [2022/40] | Entry into regional phase | 13.06.2022 | National basic fee paid | 13.06.2022 | Search fee paid | 13.06.2022 | Designation fee(s) paid | 13.06.2022 | Examination fee paid | Examination procedure | 13.06.2022 | Examination requested [2022/40] | 23.12.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 28.11.2022 | Renewal fee patent year 03 | 27.11.2023 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2014048920 (MILTENYI BIOTEC GMBH [DE]); | [A]CN108753718 (HUAIAN NUOKANG BIOLOGICAL TECH CO LTD); | International search | [Y]US2014087462 (SCHEFFOLD ALEXANDER [DE], et al); | [Y]US2016068811 (KOKAJI ANDY ISAMU [CA]); | [XY]WO2019178421 (KSQ THERAPEUTICS INC [US]) |